Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597738 · ClinicalTrials.gov registry record · NA
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
A NA study of Lung Cancer and Head and Neck Cancer, sponsored by University of Arkansas.
- Active
- Registry status
- NA
- Development phase
- 330
- Enrollment target
- 1
- Study location
NCT02597738 is a NA study of Lung Cancer and Head and Neck Cancer that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 330 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02597738, a NA study of Lung Cancer and Head and Neck Cancer, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 330 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to further advancements in biospecimens (blood cellular free component, e.g., plasma, serum, tissue, urine), in order to develop precision medicine, for lung cancer management and lung cancer screening (synergy with imaging). A co-clinical trial approach, with integrative analyses leveraging data from the treatment of genetic mouse models of lung cancer along with clinical samples and data from lung cancer patients, will be used to elucidate genomic background metrics, identify cell free DNA mutations, and further refine the liquid biopsy approach. Blood and urine samples will be analyzed for different genetic components. The tissue biopsy will be implanted into a mouse and after the cancer grows in the mouse the cancer DNA from the mouse will be compared with the human blood.
Conditions Studied
Interventions
- OTHER Fresh tissue biopsy
- OTHER Blood/Urine Sample Collection
Study Locations (1)
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2016-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02597738
The ClinicalTrials.gov registry entry for NCT02597738 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 330 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (65% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Fresh tissue biopsy is the first listed.
NCT02597738 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.
Frequently Asked Questions
What is clinical trial NCT02597738 about?
NCT02597738 is a clinical study titled "A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine". The purpose of this study is to further advancements in biospecimens (blood cellular free component, e.g., plasma, serum, tissue, urine), in order to develop precision medicine, for lung cancer management and lung cancer screening (synergy with imaging). A co-clinical trial approach, with integrativ...
What is the current status of trial NCT02597738?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 330 participants. The study started on 2016-01. Estimated completion is 2027-12.
What conditions does trial NCT02597738 study?
This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer.
What interventions are being tested in trial NCT02597738?
The interventions under investigation include: Fresh tissue biopsy (OTHER), Blood/Urine Sample Collection (OTHER).
Who is sponsoring clinical trial NCT02597738?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02597738 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.